Intestinal Microbiota in Stem Cell Transplant Transplant Admission

Recruiting now

Conditions studied: Stem Cell Transplant Complications

In brief

In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.

Key facts

Study ID

NCT04623424

Run by

Henry Ford Health System

People needed

255

Starts

2020-11-03

Expected to finish

2028-11-03

Last updated by the study team

2026-02-24

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged 18-80 years
• patients undergoing allogenic or autologous SCT for malignant hematological conditions or bone marrow failure

Where it is running

• Henry Ford Health System — Detroit, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.